4 doctors weighed in:
Is anyone familiar with the vaccine used for premature infants called synagis (palivizumab)?
4 doctors weighed in

Dr. Yash Khanna
Family Medicine
2 doctors agree
In brief: Synagis (palivizumab) vaccine
Synagis (palivizumab) is the vaccine given to new born pre term babies to prevent RSV disease, which can be fatal in small and pre term babies.

In brief: Synagis (palivizumab) vaccine
Synagis (palivizumab) is the vaccine given to new born pre term babies to prevent RSV disease, which can be fatal in small and pre term babies.
Dr. Yash Khanna
Dr. Yash Khanna
Thank
Dr. Gregory Mosolf
Pediatrics
1 doctor agrees
In brief: Palivizumab
Palivizumab or synagis (palivizumab) is a monoclonal antibody monthly injection which targets the f protein of respiratory syncytial virus (rsv).
This expensive injection is only for premature infants less than 34 weeks and 6 days gestational age at birth (or infants with chronic lung disease<24 months). Rsv causes bronchiolitis which is a lung infection. Synagis (palivizumab) has been shown to decrease hospitalizations.

In brief: Palivizumab
Palivizumab or synagis (palivizumab) is a monoclonal antibody monthly injection which targets the f protein of respiratory syncytial virus (rsv).
This expensive injection is only for premature infants less than 34 weeks and 6 days gestational age at birth (or infants with chronic lung disease<24 months). Rsv causes bronchiolitis which is a lung infection. Synagis (palivizumab) has been shown to decrease hospitalizations.
Dr. Gregory Mosolf
Dr. Gregory Mosolf
Thank
Get help from a real doctor now
Dr. Vicken Poochikian
Board Certified, Internal Medicine
38 years in practice
2M people helped
Continue
107,000 doctors available
Read more answers from doctors